Clinical trial · Interventional
Tech-TYA: eHealth Platform to Deliver Group Intervention for YA Cancer Survivors
Adapting and Testing an eHealth Platform to Deliver a Group Intervention for Young Adult Cancer Survivors
NCT05597228CI-TRIAL-00079894completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to adapt a web-based platform to deliver a group intervention for young adult cancer survivors.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cognitive-Behavioral Stress Management and Health Education | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Behavioral: Cognitive-Behavioral Stress Management and Health Education
- description
- Weekly video conference groups led by a trained facilitator
- interventionNames
- Behavioral: Cognitive-Behavioral Stress Management and Health Education
Primary outcomes (3)
- measure
- Satisfaction with the eHealth intervention delivery
- timeFrame
- At the end of the 10-week intervention, overall and weekly satisfaction scores will be compiled
- description
- Immediately after the intervention and each week participants will report their satisfaction with the full program through a brief survey.
- measure
- Acceptability of the eHealth intervention delivery
- timeFrame
- At the end of the 10-week intervention
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 39 Years
Show eligibility criteria text
Inclusion Criteria: 1. Aged 18-39 years at the time of participation 2. Diagnosed with a primary cancer between 18-39 years old 3. Finished cancer treatment with curative intent 1 month to 5 years prior to enrollment (except hormone therapy) 4. NED and no anticipated/scheduled anti-cancer treatments at the time of enrollment (except hormone therapy) 5. Able to speak and read English 6. Able and willing to give informed consent 7. Access to internet or cellular connectivity with sufficient bandwidth to participate in videoconferences (Part 2 only) Exclusion Criteria: 1. Ongoing or future anti-cancer treatments (beyond hormone therapy) are scheduled or anticipated 2. Documented or observable psychiatric or neurological disorders that could interfere with study participation (e.g., psychosis, active substance abuse) Vulnerable populations will not be included in this study.
References
Publications (2)
- DERIVEDFox RS, Badger TA, Moya S, Gudenkauf LM, Nelson MA, O'Neill RM, Leete JJ, Friedman SE, Katsanis E, Victorson DE, Sanford SD, Penedo FJ, Antoni MH, Oswald LB. An HRQOL Proof-Of-Concept Analysis of the eHealth TOGETHER Intervention for Adolescent and Young Adult Cancer Survivors: A Brief Report. Psychooncology. 2025 Jul;34(7):e70234. doi: 10.1002/pon.70234. PMID 40879639
- DERIVEDFox RS, Torres TK, Badger TA, Katsanis E, Yang D, Sanford SD, Victorson DE, Yanez B, Penedo FJ, Antoni MH, Oswald LB. Delivering a Group-Based Quality of Life Intervention to Young Adult Cancer Survivors via a Web Platform: Feasibility Trial. JMIR Cancer. 2024 Dec 4;10:e58014. doi: 10.2196/58014. PMID 39631050